Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9682 |
High Similarity |
NPD773 |
Approved |
0.9563 |
High Similarity |
NPD1569 |
Phase 2 |
0.8535 |
High Similarity |
NPD9724 |
Phase 1 |
0.8523 |
High Similarity |
NPD2892 |
Phase 1 |
0.7753 |
Intermediate Similarity |
NPD676 |
Discontinued |
0.7527 |
Intermediate Similarity |
NPD3512 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD2963 |
Phase 1 |
0.7377 |
Intermediate Similarity |
NPD412 |
Approved |
0.7349 |
Intermediate Similarity |
NPD758 |
Approved |
0.6989 |
Remote Similarity |
NPD491 |
Approved |
0.6963 |
Remote Similarity |
NPD7884 |
Discontinued |
0.6943 |
Remote Similarity |
NPD1896 |
Approved |
0.6932 |
Remote Similarity |
NPD2128 |
Phase 1 |
0.6919 |
Remote Similarity |
NPD4318 |
Clinical (unspecified phase) |
0.6868 |
Remote Similarity |
NPD509 |
Phase 3 |
0.6837 |
Remote Similarity |
NPD774 |
Phase 3 |
0.6837 |
Remote Similarity |
NPD1871 |
Approved |
0.6836 |
Remote Similarity |
NPD2660 |
Approved |
0.6836 |
Remote Similarity |
NPD2662 |
Approved |
0.6818 |
Remote Similarity |
NPD427 |
Approved |
0.6818 |
Remote Similarity |
NPD162 |
Approved |
0.6818 |
Remote Similarity |
NPD428 |
Approved |
0.6818 |
Remote Similarity |
NPD426 |
Approved |
0.6789 |
Remote Similarity |
NPD4441 |
Phase 2 |
0.6769 |
Remote Similarity |
NPD6577 |
Clinical (unspecified phase) |
0.6739 |
Remote Similarity |
NPD761 |
Approved |
0.6739 |
Remote Similarity |
NPD741 |
Approved |
0.6739 |
Remote Similarity |
NPD2478 |
Clinical (unspecified phase) |
0.6739 |
Remote Similarity |
NPD2392 |
Clinical (unspecified phase) |
0.6734 |
Remote Similarity |
NPD6264 |
Discontinued |
0.6667 |
Remote Similarity |
NPD703 |
Discontinued |
0.6667 |
Remote Similarity |
NPD2818 |
Discontinued |
0.665 |
Remote Similarity |
NPD4990 |
Clinical (unspecified phase) |
0.6649 |
Remote Similarity |
NPD924 |
Discontinued |
0.6632 |
Remote Similarity |
NPD1327 |
Discontinued |
0.663 |
Remote Similarity |
NPD2927 |
Phase 3 |
0.6615 |
Remote Similarity |
NPD207 |
Discontinued |
0.6597 |
Remote Similarity |
NPD702 |
Clinical (unspecified phase) |
0.6597 |
Remote Similarity |
NPD717 |
Approved |
0.6582 |
Remote Similarity |
NPD1043 |
Phase 3 |
0.6566 |
Remote Similarity |
NPD6265 |
Discontinued |
0.6559 |
Remote Similarity |
NPD4213 |
Clinical (unspecified phase) |
0.6558 |
Remote Similarity |
NPD2955 |
Approved |
0.6558 |
Remote Similarity |
NPD2954 |
Approved |
0.6513 |
Remote Similarity |
NPD2591 |
Phase 2 |
0.6508 |
Remote Similarity |
NPD494 |
Approved |
0.6498 |
Remote Similarity |
NPD1910 |
Approved |
0.6498 |
Remote Similarity |
NPD1911 |
Approved |
0.649 |
Remote Similarity |
NPD3843 |
Clinical (unspecified phase) |
0.6484 |
Remote Similarity |
NPD1504 |
Discontinued |
0.6477 |
Remote Similarity |
NPD461 |
Approved |
0.6462 |
Remote Similarity |
NPD1744 |
Approved |
0.6456 |
Remote Similarity |
NPD6403 |
Clinical (unspecified phase) |
0.6455 |
Remote Similarity |
NPD1567 |
Clinical (unspecified phase) |
0.6441 |
Remote Similarity |
NPD9254 |
Phase 3 |
0.6432 |
Remote Similarity |
NPD6171 |
Clinical (unspecified phase) |
0.6425 |
Remote Similarity |
NPD1528 |
Clinical (unspecified phase) |
0.6425 |
Remote Similarity |
NPD7834 |
Approved |
0.6421 |
Remote Similarity |
NPD5996 |
Clinical (unspecified phase) |
0.6417 |
Remote Similarity |
NPD3889 |
Approved |
0.6406 |
Remote Similarity |
NPD1258 |
Discontinued |
0.6398 |
Remote Similarity |
NPD1015 |
Phase 2 |
0.6398 |
Remote Similarity |
NPD1016 |
Phase 2 |
0.6398 |
Remote Similarity |
NPD2149 |
Clinical (unspecified phase) |
0.6394 |
Remote Similarity |
NPD7981 |
Discontinued |
0.6392 |
Remote Similarity |
NPD4649 |
Clinical (unspecified phase) |
0.639 |
Remote Similarity |
NPD6308 |
Phase 1 |
0.6383 |
Remote Similarity |
NPD1215 |
Discontinued |
0.6383 |
Remote Similarity |
NPD6794 |
Approved |
0.6383 |
Remote Similarity |
NPD1601 |
Approved |
0.6373 |
Remote Similarity |
NPD40 |
Phase 2 |
0.6373 |
Remote Similarity |
NPD5730 |
Phase 2 |
0.6368 |
Remote Similarity |
NPD3418 |
Clinical (unspecified phase) |
0.6368 |
Remote Similarity |
NPD3848 |
Phase 2 |
0.6368 |
Remote Similarity |
NPD1259 |
Discontinued |
0.6364 |
Remote Similarity |
NPD174 |
Discontinued |
0.6351 |
Remote Similarity |
NPD2471 |
Approved |
0.6351 |
Remote Similarity |
NPD2472 |
Approved |
0.6345 |
Remote Similarity |
NPD2793 |
Discontinued |
0.634 |
Remote Similarity |
NPD5962 |
Phase 2 |
0.633 |
Remote Similarity |
NPD1313 |
Approved |
0.633 |
Remote Similarity |
NPD1333 |
Phase 3 |
0.6321 |
Remote Similarity |
NPD2931 |
Phase 1 |
0.6318 |
Remote Similarity |
NPD3485 |
Clinical (unspecified phase) |
0.631 |
Remote Similarity |
NPD418 |
Approved |
0.631 |
Remote Similarity |
NPD513 |
Approved |
0.6304 |
Remote Similarity |
NPD3405 |
Phase 3 |
0.63 |
Remote Similarity |
NPD7709 |
Discontinued |
0.6287 |
Remote Similarity |
NPD953 |
Approved |
0.6284 |
Remote Similarity |
NPD2524 |
Discontinued |
0.6282 |
Remote Similarity |
NPD8484 |
Phase 2 |
0.6278 |
Remote Similarity |
NPD1365 |
Approved |
0.6278 |
Remote Similarity |
NPD9725 |
Approved |
0.6278 |
Remote Similarity |
NPD1366 |
Approved |
0.6278 |
Remote Similarity |
NPD1364 |
Approved |
0.6276 |
Remote Similarity |
NPD2138 |
Approved |
0.6276 |
Remote Similarity |
NPD2137 |
Approved |
0.6269 |
Remote Similarity |
NPD5943 |
Clinical (unspecified phase) |
0.6263 |
Remote Similarity |
NPD2409 |
Clinical (unspecified phase) |
0.6263 |
Remote Similarity |
NPD4320 |
Clinical (unspecified phase) |
0.6262 |
Remote Similarity |
NPD6145 |
Phase 1 |
0.6256 |
Remote Similarity |
NPD8261 |
Discontinued |
0.6239 |
Remote Similarity |
NPD3331 |
Phase 3 |
0.6237 |
Remote Similarity |
NPD5013 |
Approved |
0.6232 |
Remote Similarity |
NPD3015 |
Discontinued |
0.6231 |
Remote Similarity |
NPD5590 |
Clinical (unspecified phase) |
0.6224 |
Remote Similarity |
NPD1895 |
Discontinued |
0.6219 |
Remote Similarity |
NPD3419 |
Clinical (unspecified phase) |
0.6218 |
Remote Similarity |
NPD7006 |
Approved |
0.6204 |
Remote Similarity |
NPD6628 |
Discontinued |
0.6201 |
Remote Similarity |
NPD1941 |
Approved |
0.62 |
Remote Similarity |
NPD5646 |
Phase 2 |
0.6198 |
Remote Similarity |
NPD754 |
Clinical (unspecified phase) |
0.6198 |
Remote Similarity |
NPD3347 |
Clinical (unspecified phase) |
0.6197 |
Remote Similarity |
NPD2943 |
Clinical (unspecified phase) |
0.6196 |
Remote Similarity |
NPD2103 |
Approved |
0.6193 |
Remote Similarity |
NPD5105 |
Approved |
0.6193 |
Remote Similarity |
NPD5106 |
Approved |
0.6188 |
Remote Similarity |
NPD7722 |
Suspended |
0.6188 |
Remote Similarity |
NPD2747 |
Clinical (unspecified phase) |
0.6186 |
Remote Similarity |
NPD1556 |
Clinical (unspecified phase) |
0.6181 |
Remote Similarity |
NPD3378 |
Clinical (unspecified phase) |
0.6179 |
Remote Similarity |
NPD4495 |
Phase 1 |
0.6173 |
Remote Similarity |
NPD1873 |
Clinical (unspecified phase) |
0.6173 |
Remote Similarity |
NPD1928 |
Discontinued |
0.6168 |
Remote Similarity |
NPD5679 |
Clinical (unspecified phase) |
0.6166 |
Remote Similarity |
NPD1037 |
Clinical (unspecified phase) |
0.6157 |
Remote Similarity |
NPD8256 |
Approved |
0.6157 |
Remote Similarity |
NPD8258 |
Clinical (unspecified phase) |
0.6157 |
Remote Similarity |
NPD8257 |
Approved |
0.6146 |
Remote Similarity |
NPD1174 |
Phase 2 |
0.6146 |
Remote Similarity |
NPD2875 |
Clinical (unspecified phase) |
0.6141 |
Remote Similarity |
NPD1029 |
Clinical (unspecified phase) |
0.6141 |
Remote Similarity |
NPD1030 |
Approved |
0.6141 |
Remote Similarity |
NPD1027 |
Approved |
0.6138 |
Remote Similarity |
NPD2480 |
Clinical (unspecified phase) |
0.6132 |
Remote Similarity |
NPD7409 |
Clinical (unspecified phase) |
0.6122 |
Remote Similarity |
NPD2930 |
Clinical (unspecified phase) |
0.6119 |
Remote Similarity |
NPD760 |
Approved |
0.6117 |
Remote Similarity |
NPD2308 |
Clinical (unspecified phase) |
0.6117 |
Remote Similarity |
NPD465 |
Clinical (unspecified phase) |
0.6117 |
Remote Similarity |
NPD1042 |
Clinical (unspecified phase) |
0.6116 |
Remote Similarity |
NPD2062 |
Phase 2 |
0.6101 |
Remote Similarity |
NPD5270 |
Discontinued |
0.61 |
Remote Similarity |
NPD3913 |
Clinical (unspecified phase) |
0.61 |
Remote Similarity |
NPD645 |
Clinical (unspecified phase) |
0.6093 |
Remote Similarity |
NPD7276 |
Approved |
0.6093 |
Remote Similarity |
NPD7277 |
Approved |
0.6087 |
Remote Similarity |
NPD2104 |
Approved |
0.6087 |
Remote Similarity |
NPD2102 |
Approved |
0.6085 |
Remote Similarity |
NPD2026 |
Approved |
0.6082 |
Remote Similarity |
NPD966 |
Clinical (unspecified phase) |
0.6078 |
Remote Similarity |
NPD460 |
Discontinued |
0.6078 |
Remote Similarity |
NPD2320 |
Discontinued |
0.6071 |
Remote Similarity |
NPD1272 |
Clinical (unspecified phase) |
0.6068 |
Remote Similarity |
NPD2880 |
Discontinued |
0.6065 |
Remote Similarity |
NPD4447 |
Phase 2 |
0.6062 |
Remote Similarity |
NPD5412 |
Discontinued |
0.6059 |
Remote Similarity |
NPD6626 |
Approved |
0.6056 |
Remote Similarity |
NPD4472 |
Approved |
0.6056 |
Remote Similarity |
NPD4471 |
Approved |
0.6055 |
Remote Similarity |
NPD5129 |
Phase 3 |
0.6053 |
Remote Similarity |
NPD1122 |
Clinical (unspecified phase) |
0.605 |
Remote Similarity |
NPD5438 |
Approved |
0.605 |
Remote Similarity |
NPD5439 |
Approved |
0.6048 |
Remote Similarity |
NPD6888 |
Discontinued |
0.6047 |
Remote Similarity |
NPD2794 |
Discontinued |
0.6042 |
Remote Similarity |
NPD3361 |
Phase 1 |
0.6038 |
Remote Similarity |
NPD5011 |
Clinical (unspecified phase) |
0.6038 |
Remote Similarity |
NPD6328 |
Clinical (unspecified phase) |
0.6038 |
Remote Similarity |
NPD8410 |
Clinical (unspecified phase) |
0.6031 |
Remote Similarity |
NPD6827 |
Clinical (unspecified phase) |
0.6031 |
Remote Similarity |
NPD6828 |
Phase 2 |
0.603 |
Remote Similarity |
NPD952 |
Approved |
0.6027 |
Remote Similarity |
NPD6508 |
Approved |
0.602 |
Remote Similarity |
NPD5757 |
Discontinued |
0.602 |
Remote Similarity |
NPD4940 |
Approved |
0.602 |
Remote Similarity |
NPD3348 |
Phase 2 |
0.6019 |
Remote Similarity |
NPD2847 |
Phase 2 |
0.6019 |
Remote Similarity |
NPD2316 |
Clinical (unspecified phase) |
0.601 |
Remote Similarity |
NPD9582 |
Phase 3 |
0.6009 |
Remote Similarity |
NPD8075 |
Discontinued |
0.6 |
Remote Similarity |
NPD1404 |
Approved |
0.6 |
Remote Similarity |
NPD1403 |
Approved |
0.6 |
Remote Similarity |
NPD680 |
Discontinued |
0.599 |
Remote Similarity |
NPD6224 |
Clinical (unspecified phase) |
0.599 |
Remote Similarity |
NPD5269 |
Clinical (unspecified phase) |
0.599 |
Remote Similarity |
NPD2009 |
Clinical (unspecified phase) |
0.5989 |
Remote Similarity |
NPD1303 |
Phase 1 |
0.5982 |
Remote Similarity |
NPD3521 |
Phase 2 |
0.5978 |
Remote Similarity |
NPD2528 |
Approved |
0.5973 |
Remote Similarity |
NPD4414 |
Discontinued |
0.5973 |
Remote Similarity |
NPD5935 |
Discontinued |
0.5973 |
Remote Similarity |
NPD8317 |
Phase 2 |
0.5973 |
Remote Similarity |
NPD8004 |
Discontinued |
0.5973 |
Remote Similarity |
NPD8316 |
Phase 2 |
0.5972 |
Remote Similarity |
NPD8458 |
Clinical (unspecified phase) |
0.597 |
Remote Similarity |
NPD1227 |
Phase 2 |
0.5962 |
Remote Similarity |
NPD4470 |
Phase 2 |
0.5961
|
Remote Similarity |
NPD2775 |
Phase 1 |